A Randomized Trial of ω-3 Fatty Acid Supplementation and Circulating Lipoprotein Subclasses in Healthy Older Adults
Authors:
- 7 April 2022
- journal article
- research article
- Published by Elsevier in The Journal of Nutrition
- Vol. 152 (7) , 1675-1689
Abstract
Omega-3 (n–3) PUFAs are recognized for triglyceride-lowering effects in people with dyslipidemia, but it remains unclear if n–3-PUFA intake influences lipoprotein profiles in older adults without hypertriglyceridemia. The objective was to determine the effect of n–3-PUFA supplementation on plasma lipoprotein subfractions in healthy older men and women in the absence of cardiovascular disease (CVD) or hypertriglyceridemia. This was a secondary analysis and considered exploratory. Thirty young (20–35 y old) and 54 older (65–85 y old) men and women were enrolled in the study. Fasting plasma samples were collected. After baseline sample collection, 44 older adults were randomly assigned to receive either n–3-PUFA ethyl esters (3.9 g/d) or placebo (corn oil) for 6 mo. Pre- and postintervention plasma samples were used for quantitative lipoprotein subclass analysis using high-resolution proton NMR spectroscopy. The number of large, least-dense LDL particles decreased 17%–18% with n–3 PUFAs compared with placebo (P < 0.01). The number of small, dense LDL particles increased 26%–44% with n–3 PUFAs compared with placebo (∼11% decrease; P < 0.01). The cholesterol content of large HDL particles increased by 32% with n–3 PUFAs and by 2% in placebo (P < 0.01). The cholesterol content of small HDL particles decreased by 23% with n–3 PUFAs and by 2% in placebo (P < 0.01). Despite increasing abundance of small, dense LDL particles that are associated with CVD risk, n–3 PUFAs reduced total triglycerides, maintained HDL, reduced systolic blood pressure, and shifted the HDL particle distribution toward a favorable cardioprotective profile in healthy older adults without dyslipidemia. This study suggests potential benefits of n–3-PUFA supplementation to lipoprotein profiles in healthy older adults without dyslipidemia, which should be considered when weighing the potential health benefits against the cost and ecological impact of widespread use of n–3-PUFA supplements. This trial was registered at clinicaltrials.gov as NCT03350906.Keywords
Funding Information
- National Center for Advancing Translational Sciences (UL1 TR002377)
- National Institute on Aging (R01 AG054454)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (T32 AR056950)
This publication has 35 references indexed in Scilit:
- Dietary omega-3 fatty acid supplementation increases the rate of muscle protein synthesis in older adults: a randomized controlled trialThe American Journal of Clinical Nutrition, 2011
- Observational study of lipid profile and LDL particle size in patients with metabolic syndromeLipids in Health and Disease, 2011
- Rapid measurement of plasma free fatty acid concentration and isotopic enrichment using LC/MSJournal of Lipid Research, 2010
- GPR120 Is an Omega-3 Fatty Acid Receptor Mediating Potent Anti-inflammatory and Insulin-Sensitizing EffectsCell, 2010
- Effects of marine n-3 fatty acid supplementation on lipoprotein subclasses measured by nuclear magnetic resonance in subjects with type II diabetesEuropean Journal of Clinical Nutrition, 2007
- Influence of α-linolenic acid and fish-oil on markers of cardiovascular risk in subjects with an atherogenic lipoprotein phenotypeAtherosclerosis, 2005
- High-Density Lipoprotein Subpopulation Profile and Coronary Heart Disease Prevalence in Male Participants of the Framingham Offspring StudyArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Relationships of low density lipoprotein subfractions to angiographically defined coronary artery disease in young survivors of myocardial infarctionAtherosclerosis, 1991
- High density lipoproteins and coronary atherosclerosis. A strong inverse relation with the largest particles is confined to normotriglyceridemic patients.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1991
- Paradoxical elevation of LDL apoprotein B levels in hypertriglyceridaemic patients and normal subjects ingesting fish oilAtherosclerosis, 1986